MARLE GROUP
Acquired by
THE CARLYLE GROUP
MARLE GROUP acquired by THE CARLYLE GROUP
Target
MARLE GROUP
Acquirer
THE CARLYLE GROUP
Context
The Carlyle Group has acquired an 80% majority stake in Marle S.A. The company's President, Bernard Marle, along with his family, has reinvested to retain a 20% stake. This Primary LBO is designed to support the company's growth in a market expanding at 8% annually. The transaction structure includes a senior debt package co-arranged by CIC Est and LCL, as well as a vendor loan (credit-vendeur). Carlyle aims to professionalize the company and accelerate its international expansion.
MARLE GROUP, which reported an EBITDA margin of LOGIN in 2009, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN discount to the 13.4x average currently observed in the Healthcare & Pharma sector.
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Marle Group is a European leader in the manufacturing of orthopedic, trauma, and spine implants. Backed by the family investment holding Dentressangle, Marle operates as a Contract Development and Manufacturing Organization (CDMO) for major global medical device companies.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with MARLE GROUP
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 12/2023 | MARLE GROUP | NOWAK | FRANCE | Implants & Prosthetics | Marle Group has acquired Nowak from a consortium of private equity investors led by Siparex Midcap, alongside Bpifrance, Unexo, and the management team. This acquisition strengthens Marle's vertical integration by adding specialized casting capabilities. The deal follows a successful transformation period under Siparex (2018-2023), where Nowak shifted its focus toward the medical sector and acquired Belmonte. The transaction was financed via a unitranche debt facility provided by Capza. |
| 10/2019 | DENTRESSANGLE | MARLE GROUP | FRANCE | Implants & Prosthetics | Dentressangle has entered into exclusive negotiations to acquire a majority stake in Marle Group from IK Investment Partners. The deal was preemptive |
| 05/2016 | IK PARTNERS | MARLE GROUP | FRANCE | Implants & Prosthetics | IK Investment Partners has agreed to acquire a majority stake in Marle International from Carlyle Europe Technology. The transaction values the company at approximately EUR350 million. This "Limited Auction" process saw IK prevail over competitors Astorg, Permira, and Ergon. As part of the deal, Carlyle reinvests as a minority shareholder, alongside the founding Marle family and the management team. The acquisition aims to support Marle's continued international expansion and external growth strategy. |
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.